Related Experiment Videos
Validation of scoring systems for predicting severe community-acquired pneumonia
Hajime Fukuyama1, Tadashi Ishida, Hiromasa Tachibana
1Department of Respiratory Medicine, Kurashiki Central Hospital, Japan. fukuyama_hajime@hosp.pref.okinawa.jp
Internal Medicine (Tokyo, Japan)
|September 17, 2011
Summary
The España rule effectively identifies severe community-acquired pneumonia (CAP) with high sensitivity and negative predictive value. While performing well, all scoring systems have limitations in predicting adverse outcomes for CAP patients.
Area of Science:
- Pulmonology
- Critical Care Medicine
- Epidemiology
Background:
- Several scoring systems exist to identify severe community-acquired pneumonia (CAP).
- The España rule was recently developed to predict mortality, mechanical ventilation, and septic shock in CAP patients.
- Performance of the España rule against other established scoring systems requires evaluation.
Purpose of the Study:
- To assess the performance of the España rule in identifying severe CAP.
- To compare the España rule with other pneumonia severity scoring systems (PSI, CURB-65, A-DROP, IDSA/ATS, SMART-COP).
- To evaluate the association of España rule criteria with adverse outcomes.
Main Methods:
- Prospective study of 505 hospitalized CAP patients (April 2007 - May 2009).
- Calculated scores using España rule, PSI, CURB-65, A-DROP, IDSA/ATS, and SMART-COP.
- Compared sensitivity, specificity, PPV, and NPV for severe CAP outcomes (in-hospital death, mechanical ventilation, septic shock).
Main Results:
- Overall in-hospital mortality was 6.5%; 12.3% of patients had severe CAP.
- The España rule demonstrated the highest sensitivity and NPV for predicting severe CAP.
- IDSA/ATS rule and SMART-COP were effective predictors for ICU admission.
Conclusions:
- The España rule is a valuable tool for identifying patients with severe CAP.
- Different severity scoring systems possess distinct advantages and limitations for predicting adverse outcomes in CAP.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...